New multiple sclerosis treatment trial compares stem cell transplantation to best available drugs
National Institutes of Health (NIH) sent this bulletin at 01/07/2020 10:30 AM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
01/07/2020 09:30 AM EST
NIH-funded study focuses on severe forms of relapsing MS.